Ifp Advisors, Inc Lexicon Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 30, 2024	BUY	$1.3 - $3.58 $195 - $537	150 New	150 $0
Q4 2022 Feb 07, 2023	BUY	$1.8 - $2.56 $3,600 - $5,120	2,000 New	2,000 $25,000
Q2 2018 Aug 07, 2018	SELL	$7.8 - $13.69 $2,340 - $4,107	-300 Closed	0 $0
Q1 2018 Jun 03, 2019	BUY	$7.86 - $11.39 $2,358 - $3,417	300 New	300 $3,000
Q1 2018 May 09, 2018	SELL	$7.86 - $11.39 $2,358 - $3,417	-300 Closed	0 $0
Q4 2017 Jan 24, 2018	SELL	$8.77 - $12.28 $15,978 - $22,374	-1,822 Reduced 85.86%	300 $0
Q3 2017 Oct 30, 2017	SELL	$12.17 - $16.3 $669 - $896	-55 Reduced 2.53%	2,122 $26,000
Q2 2017 Jun 03, 2019	SELL	N/A	-470 Reduced 17.76%	2,177 $36,000
Q1 2017 Jun 03, 2019	BUY	N/A	2,625 Added 11931.82%	2,647 $38,000
Q4 2016 Jun 03, 2019	BUY	N/A	22	22 $0

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $145M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.